Search results for abx831300

Bococizumab, Abbexa, abx831300

Bococizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PCSK9/NARC1/PC9, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Bococizumab has been used in trials studying the treatment and prevention of Dyslipidemia, Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease, and Heterozygous Familial Hypercholesterolemia.